REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 38.29B KRW in the quarter ending September 30, 2024, with 2.27% growth. This brings the company's revenue in the last twelve months to 149.84B, down -0.49% year-over-year. In the year 2023, REYON Pharmaceutical had annual revenue of 151.07B, down -1.93%.

• Revenue (ttm): 149.84B
• Revenue Growth: -0.49%
• P/S Ratio: 1.58
• Revenue / Employee: 334.47M
• Employees: 448
• Market Cap: 236.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%
Dec 31, 2019	131.56B	8.57B	6.97%